AAV2-GDNF gene therapy clinical trials

A Study of AAV2-GDNF in Adults With Moderate Parkinson's Disease (REGENERATE-PD)

This study is testing a new gene therapy, AAV2-GDNF, for people with moderate Parkinson's disease. We want to see if it's safe and helps improve symptoms. It involves a single surgery and comparing the gene therapy to a control surgery.